Opendata, web and dolomites


My own bio-imprint as asset for competitive advantage

Total Cost €


EC-Contrib. €






Project "MYBIOASSET" data sheet

The following table provides information about the project.


Organization address
postcode: 31195
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.4. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology)
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-12-01   to  2016-05-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INBIOLEV SL ES (AIZOAIN) coordinator 50˙000.00


 Project objective

'Microorganisms are the basic pillars of global industries like wine production, brewing and bread making. Producers elaborate useful and valuated products controlling the microbial activity on the raw material to obtain the desired results. In these sectors, in most cases, two opposite drivers determine the competitive strength and position of each competing company:• The singularity and differentiation of the product. This driver is the responsible for the scarcity component of the competitive advantage. A company is more competitive in the extent their products cannot be replicated by competitors. Influences mainly the “price” component of the marketing mix; the more singular and scarce the higher margin to raise the price.• The efficiency and robustness of the production process. The other component of competitive advantage is related to the excellence in operations. The production capacity and the optimization of processes, increase the profitability through reduction of production costs and defective product.In most cases, very differentiated or high quality food requires complex and expensive processes; and very efficient and robust processes drive to undifferentiated and standardized products. This is the case of wine industry, in which differentiation of the product has been sacrificed in favour of efficiency of the process. LEV2050 was created to recover the ancient diversity of wines while benefiting for most modern production technologies. This document is particularly relevant for winemaking but the business principles are scalable to any microbiota based industry.With LEV2050 winemakers can, at the same time, develop their competitive advantage from the differentiation of their products, and from the efficiency and robustness of 100% trustable fermentation processes' '

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MYBIOASSET" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MYBIOASSET" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.4.;H2020-EU.2.3.1.)

FlexiBiome (2018)

Next Generation Microbiome Platform

Read More  

sFilm-FS (2018)

Fibrin sealant for anastomotic leaks and haemostasis

Read More  

SEQURE (2018)

Targeted complete next-generation sequencing for companion diagnostics and personalized treatment of cancer

Read More